Hong Kong Investor Relations Association Announces Winners of the 9th IR Awards 2023
HONG KONG, Jun 28, 2023 – (ACN Newswire) – Hong Kong Investor Relations Association (“HKIRA”)…
HONG KONG, Jun 28, 2023 – (ACN Newswire) – Hong Kong Investor Relations Association (“HKIRA”)…
DOVER, DE, Jun 28, 2023 – (ACN Newswire) – Pacific Green Technologies, Inc. (“Pacific Green”),…
Company also publishes significantly enhanced Task Force on Climate-related Financial Disclosures Report HARTFORD, Conn.–(BUSINESS WIRE)–The…
Annual Channel Futures 2023 MSP 501 ranks CDS 39th on list of best-in-class businesses growing…
LOS ANGELES–(BUSINESS WIRE)–Prism Labs, a startup democratizing access to 3D bodymapping technology, is excited to…
Intelligent open source platform enables developers to get started with real-time data in less than…
VANCOUVER, British Columbia, June 28, 2023 (GLOBE NEWSWIRE) — June 28, 2023 – Sirona Biochem…
VANCOUVER, British Columbia, June 28, 2023 (GLOBE NEWSWIRE) — June 28, 2023 – Sirona Biochem…
Alport syndrome is a rare progressive hereditary glomerular kidney disease caused by variants in COL4A…
RVT-3101 demonstrated improved efficacy results from the induction to chronic period in the TUSCANY-2 Phase…
Alport syndrome is a rare progressive hereditary glomerular kidney disease caused by variants in COL4A…
OREM, Utah, June 28, 2023 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (OTCQB: RSCF), a leading…
RVT-3101 demonstrated improved efficacy results from the induction to chronic period in the TUSCANY-2 Phase…
OREM, Utah, June 28, 2023 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (OTCQB: RSCF), a leading…
SAN DIEGO, June 28, 2023 (GLOBE NEWSWIRE) — Ambrx Biopharma Inc., or Ambrx (or the…
SAN DIEGO, June 28, 2023 (GLOBE NEWSWIRE) — Ambrx Biopharma Inc., or Ambrx (or the…
BOSTON, June 28, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
BOSTON, June 28, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
SAN DIEGO, June 28, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
Former Awardee and Artelo Employee, Professor Saoirse O’Sullivan will Present the 2023 Recipient with the…